Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionEvanson Asset Management, LLC
Latest Disclosed Ownership1,603 shares
Latest Disclosed Value $ 564,172
Evanson Asset Management, LLC reports 2.79% decrease in ownership of AMGN / Amgen Inc.

On April 8, 2026 - Evanson Asset Management, LLC filed a 13F-HR form disclosing ownership of 1,603 shares of Amgen Inc. (CH:AMGN) valued at $564,172 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 1,649 shares of Amgen Inc.. This represents a change in shares of -2.79% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F AMGEN COM 031162100 1,603 -46 -2.79 564 4.64 0.0303
2026-01-12 2025-12-31 13F AMGEN COM 031162100 1,649 -114 -6.47 540 8.45 0.0291
2025-10-14 2025-09-30 13F AMGEN COM 031162100 1,763 -44 -2.43 498 -1.39 0.0281
2025-07-15 2025-06-30 13F AMGEN COM 031162100 1,807 6 0.33 505 -10.16 0.0314
2025-04-22 2025-03-31 13F AMGEN COM 031162100 1,801 136 8.17 561 29.56 0.0397
2025-01-16 2024-12-31 13F AMGEN COM 031162100 1,665 2 0.12 434 -19.07 0.0297
2024-10-07 2024-09-30 13F AMGEN COM 031162100 1,663 -7 -0.42 536 2.69 0.0378
2024-07-12 2024-06-30 13F AMGEN COM 031162100 1,670 2 0.12 522 9.92 0.0384
2024-04-12 2024-03-31 13F AMGEN COM 031162100 1,668 2 0.12 474 -1.04 0.0353
2024-01-18 2023-12-31 13F AMGEN COM 031162100 1,666 35 2.15 480 9.36 0.0390
2023-10-19 2023-09-30 13F AMGEN COM 031162100 1,631 -10 -0.61 438 20.33 0.0404
2023-07-11 2023-06-30 13F AMGEN COM 031162100 1,641 2 0.12 364 -8.08 0.0332
2023-04-13 2023-03-31 13F AMGEN COM 031162100 1,639 2 0.12 396 -7.69 0.0392
2023-01-26 2022-12-31 13F/A-1 AMGEN COM 031162100 1,637 -183 -10.05 430 4.63 0.0462
2023-01-13 2022-12-31 13F AMGEN COM 031162100 1,685 -135 380 0.0000
2022-10-12 2022-09-30 13F AMGEN COM 031162100 1,820 -34 -1.83 410 -9.09 0.0481
2022-07-13 2022-06-30 13F AMGEN COM 031162100 1,854 2 0.11 451 0.67 0.0496
2022-04-11 2022-03-31 13F AMGEN COM 031162100 1,852 -6 -0.32 448 7.18 0.0435
2022-01-19 2021-12-31 13F AMGEN COM 031162100 1,858 -1 -0.05 418 -7.32 0.0372
2021-10-13 2021-09-30 13F AMGEN COM 031162100 1,859 2 0.11 451 -0.44 0.0463
2021-07-14 2021-06-30 13F AMGEN COM 031162100 1,857 9 0.49 453 -1.52 0.0471
2021-04-23 2021-03-31 13F AMGEN COM 031162100 1,848 24 1.32 460 9.79 0.0679
2021-01-22 2020-12-31 13F AMGEN COM 031162100 1,824 177 10.75 419 0.00 0.0667
2020-10-13 2020-09-30 13F AMGEN COM 031162100 1,647 -99 -5.67 419 1.70 0.0757
2020-07-13 2020-06-30 13F AMGEN COM 031162100 1,746 2 0.11 412 16.38 0.0816
2020-04-24 2020-03-31 13F AMGEN COM 031162100 1,744 -346 -16.56 354 -29.76 0.0844
2020-01-13 2019-12-31 13F AMGEN COM 031162100 2,090 4 0.19 504 24.75 0.0990
2019-10-11 2019-09-30 13F AMGEN COM 031162100 2,086 -6 -0.29 404 4.66 0.0830
2019-07-11 2019-06-30 13F AMGEN COM 031162100 2,092 -450 -17.70 386 -20.08 0.0780
2019-04-09 2019-03-31 13F AMGEN COM 031162100 2,542 342 15.55 483 12.85 0.0997
2019-01-17 2018-12-31 13F AMGEN COM 031162100 2,200 532 31.89 428 23.70 0.0978
2018-10-10 2018-09-30 13F AMGEN COM 031162100 1,668 -558 -25.07 346 -15.82 0.0703
2018-07-11 2018-06-30 13F AMGEN COM 031162100 2,226 542 32.19 411 43.21 0.0815
2018-04-05 2018-03-31 13F AMGEN COM 031162100 1,684 -148 -8.08 287 -9.75 0.0591
2018-02-05 2017-12-31 13F AMGEN COM 031162100 1,832 345 23.20 318 14.39 0.0645
2017-11-14 2017-09-30 13F AMGEN COM 031162100 1,487 12 0.81 278 9.45 0.0594
2017-07-10 2017-06-30 13F AMGEN COM 031162100 1,475 -1 -0.07 254 4.96 0.0585
2017-04-19 2017-03-31 13F AMGEN COM 031162100 1,476 66 4.68 242 16.91 0.0597
2017-02-10 2016-12-31 13F AMGEN COM 031162100 1,410 2 0.14 207 -11.91 0.0576
2016-10-18 2016-09-30 13F AMGEN COM 031162100 1,408 20 1.44 235 11.37 0.0669
2016-07-19 2016-06-30 13F AMGEN COM 031162100 1,388 1,388 0.00 211 0.0638
2015-07-13 2015-06-30 13F AMGEN COM 031162100 0 -1,771 -100.00 0 -100.00
2015-05-15 2015-03-31 13F AMGEN COM 031162100 1,771 -1,445 -44.93 218 -57.42 0.0885
2015-02-09 2014-12-31 13F AMGEN COM 031162100 3,216 3,216 512 0.1890
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.